Invasive fungal infections are rare in pediatric and young adult autologous hematopoietic stem cell transplant patients
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.31336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Jane Koo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Invasive Fungal Infections, Transplantation, Autologous. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Pediatric and young adult patients undergoing autologous hematopoietic stem cell transplant (auto‐HSCT) face a crucial, yet understudied, risk of invasive fungal infections (IFI), especially compared to allogeneic transplants. This gap underscores the need for research in pediatric patients undergoing auto‐HSCT. Our objective was to evaluate the incidence of IFI in pediatric and young adult patients during the first year after auto‐HSCT. Materials and methods We conducted a single‐center retrospective analysis of 150 pediatric and young adult auto‐HSCT patients who underwent transplant from January 2013 to January 2023. We focused on IFI incidence within the first‐year post transplant, using the European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) criteria for IFI identification.
Results
Among the 150 patients analyzed, with 240 unique transplant episodes, the primary indication was neuroblastoma (37.3%), and micafungin was extensively used for prophylaxis (82.7%). There was an absence of IFI from yeast and mold species, suggesting a low IFI risk in this cohort. The incidence of IFI in pediatric auto‐HSCT recipients receiving micafungin primary antifungal prophylaxis is rare.
Conclusions
The findings advocate for further research to refine prophylaxis guidelines and highlight the need for individualized risk assessment to optimize post‐transplant care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio, USA.
ORCID-Profile: Jane Koo, John Huber, Priscila Badia, Stella M Davies, Christopher E Dandoy
Zitieren
APA
Koo, J., Huber, J., Badia, P., Dunseath, C., O'Connor, G., Davies, S. M., & Dandoy, C. E. (2024). Invasive fungal infections are rare in pediatric and young adult autologous hematopoietic stem cell transplant patients. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31336
Vancouver
Koo J, Huber J, Badia P, Dunseath C, O'Connor G, Davies SM, et al. Invasive fungal infections are rare in pediatric and young adult autologous hematopoietic stem cell transplant patients. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31336
BibTeX
@article{Koo2024,
author = {Koo, Jane and Huber, John and Badia, Priscila and Dunseath, Chloe and O'Connor, Gabby and Davies, Stella M and Dandoy, Christopher E},
title = {Invasive fungal infections are rare in pediatric and young adult autologous hematopoietic stem cell transplant patients},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.31336}
}
EUVIMED